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Background: There is a current lack of any composite measure for the effective tracking
and monitoring of clinical change in individuals exposed to repetitive head impacts (RHI).
The aim of this study is to create a composite instrument for the purposes of detecting
change over time in cognitive and behavioral function in individuals exposed to RHI.
Methods: The data to derive the composite instrument came from the Professional
Fighters Brain Health Study (PFBHS), a longitudinal study of active and retired
professional fighters [boxers and mixed martial arts (MMA) fighters] and healthy controls.
Participants in the PFBHS underwent assessment on an annual basis that included
computerized cognitive testing and behavioral questionnaires. Multivariate logistic
regression models were employed to compare active fighters (n = 117) with controls
(n = 22), and retired fighters (n = 26) with controls to identify the predictors that could be
used to differentiate the groups over time. In a second step, linear discriminant analysis
was performed to derive the linear discriminant coefficients for the three groups by using
the predictors from the two separate logistic regression models.
Results: The composite scale is a weighted linear value of 12 standardized scores
consisting of both current and yearly change scores in domains including: processing
speed, choice reaction time, semantic fluency, letter fluency, and Barrett Impulsiveness
Scale. Because the weighting of values differed between active and retired fighters, two
versions emerged. The mean and standard deviation ratio (MSDR) showed that the new
index had better sensitivity compared to the individual measures, with the ratio of MSDR
of the new index to that of the existing measures of at least 1.84.
Conclusion: With the increasing need for tools to follow individuals exposed to RHI and
the potential of clinical trials on the horizon for CTE, the RHICI is poised to serve as an
initial approach to a composite clinical measure.
Keywords: traumatic brain injury, chronic traumatic encephalopathy, composite index, cognition, composite index
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INTRODUCTION

at least 2 years, and did not intend to return to competition
(there were too few retired MMA fighters to include as a separate
group). Control subjects were recruited from outreach efforts
in the community and could not have any self-reported prior
history of neurological disorders, head trauma, military service,
or participation at a high school level or higher in a combat
sport or a sport in which head impacts can be anticipated
to occur, such as American football, wrestling, hockey, rugby,
soccer, or rodeo. All participants were required to be able to
read at a minimum at a 4th grade level but were not otherwise
screened for cognitive status or subjective complaints prior
to enrollment.
Enrollment in the PFBHS began in 2011 and has been
continuous since. Each participant is seen on an annual basis,
and for active fighters, not sooner than 45 days after a
sanctioned fight. The PFBHS was approved by the Cleveland
Clinic Institutional Review Board and written informed consent
was obtained from all participants. More detailed methods
of recruitment and study procedures have been described
previously (16).
At baseline and each annual visit, a battery of tests and
information were acquired including magnetic resonance
imaging (MRI) of the brain, computerized cognitive testing,
behavioral questionnaires, and exposure history. Participants
answered questionnaires with the assistance of the study
coordinator that collected information on demographics;
educational attainment; medical history including concurrent
illnesses and prescribed medications; previous head trauma, both
related and unrelated to athletic activities; and prior involvement
in other contacts sports.
Cognitive function was assessed by two computerized
cognitive test batteries and verbally administered measures of
verbal fluency. One computerized battery consists of four subtests
of the CNS Vital SignsTM (CNS Vital SignsTM , North Carolina)
including verbal memory, symbol digit coding, Stroop and
a finger tapping test. CNS Vital SignsTM offers robust and
reliable measurements of cognition, which are computerized; test
performance is supervised by a technician (17). Results from
these tests are used to create scores in the following clinical
domains: verbal memory, processing speed, psychomotor speed
and reaction time. The other computerized cognitive assessment,
C3 Logix, an iPad-based test that includes a processing speed test,
Trail Making Test Parts A and B, simple and choice reaction
time paradigms along with a balance measure (18). Tests of
verbal fluency include both letter (words that start with “f ”) and
semantic (animals) fluency tasks.
Behavioral assessment was obtained through administration
of the Patient Health Questionnaire (PHQ 9) that evaluates the
presence of depressive symptoms and the Barrett Impulsiveness
Scale (BIS II) (19, 20). The BIS II comprises 30 questions,
which have been shown to load on six factors (attention,
cognitive instability, motor, perseverance, self-control, and
cognitive complexity); the items loading on these factors
provide the subscales for the instrument. For both total
and subscale scores, higher scores refer to higher levels
of impulsiveness.

There is increasing interest in understanding the long term
neurological effects of exposure to repetitive head impacts
(RHI) including Chronic Traumatic Encephalopathy (CTE), with
the anticipation of developing therapeutic interventions (1–
3). The tools we apply to identify cognitive and behavioral
changes in those exposed to RHI are borrowed from standard
neuropsychological tests and behavioral instruments. While
casting a broad net by utilizing an array of discrete tests may
capture the range of deficits one might detect in those exposed
to RHI, it would be helpful to have a single measure that can be
used to track change clinically and in epidemiological studies and
clinical trials. Currently, though, we lack any composite measure
that is focused on the domains that are most likely to show change
due to RHI.
To develop and validate new test batteries takes significant
time and effort. Composite scales can be produced by
either consensus (e.g., United Parkinson’s Disease Research
Scale) or data driven [e.g., Alzheimer’s disease Composite
Score (ADCOMS)] strategies (4–6). The data-driven approach
leverages existing scales and uses mathematical approaches to
identify the items most sensitive to change in the group being
studied and applies weighting to improve performance.
Previous work on neuropsychological and behavioral changes
in those exposed to RHI have tended to be cross sectional and
have reported deficits in domains such as memory, informationprocessing speed, finger-tapping speed, complex attentional
tasks, and frontal-executive functions (7–9). However, our
experience from the Professional Fighters Brain Health Study
(PFBHS), a longitudinal study of professional boxers and mixed
martial arts (MMA) fighters, has suggested that not all cognitive
domains are affected equally, particularly when viewed on a
longitudinal basis (10–13). Moreover, it has been reported that
behavioral changes can be a prominent feature in those exposed
to RHI, particularly aspects of impulsivity and behavioral
dyscontrol (14, 15).
The aim of this study is to create a composite instrument that
could detect change over time in clinical measures in individuals
exposed to RHI. This was accomplished by utilizing data obtained
from the Professional Fighters Brain Health Study (16). The
composite scale—termed Repetitive Head Impact Composite
Index (RHICI)—if validated in prospective studies, could be used
for natural history studies of RHI, clinical trials of traumatic
encephalopathy syndrome (TES), or other mild traumatic brain
injury research.

METHODS
The data used for the RHICI came from the PFBHS, a
convenience sample consisting of active and retired professional
fighters (boxers and MMA fighters) and healthy controls. Active
fighters were required to have at least 1 professional fight within
2 years of enrollment and be training with the intent to compete.
Retired fighters were included if they had been boxers, had a
minimum of 10 professional fights, had no sanctioned fights for
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Statistical Methods

the measures that can be used in the next step in developing
a new composite index. The selected predictors that did not
meet the direction were removed from the final model. The final
model had a total of 12 measures among the 32 predictors from
cognitive and behavioral assessments.
In the final step of composite construction, we performed
discriminant analysis in which the group variable (control, active
fighters, and retired fighters) was used as the outcome, and
the 12 measures were included in the model as independent
variables. Discriminant analysis was performed to derive the
linear discriminant coefficients for the 12 measures in each
group. We then rescaled the new index to a range of 0–20 with
lower scores considered to be normal.

Samples
Data from the PFBHS study was used to develop a new composite
index for individuals exposed to RHI. We included participants
having at least three study visits over a minimum of 2 years. The
normal controls (n = 22) were used as the reference group with
the assumption that they were the least likely to show decline in
cognitive measures over a several year period. The conceptual
framework informing the index was to identify and create a
composite from those cognitive and behavioral measures that
were able to best differentiate over time the active fighters (n =
117) from the controls and the retired fighters (n = 26) from
the controls.
The initial step was to examine the correlation of the cognitive
and behavioral variables with each other in a correlation matrix.
This was performed to avoid the problem that could be caused by
multiple co-linearity—when two highly correlated variables are
both included in a statistical model may result in the sign change
of parameter estimates. When two or more measures were highly
correlated (p-value of 0.05), the study team adjudicated which
one was clinically more important.
After removing the highly correlated measures, 16 items from
cognitive and behavioral assessments were initially included in
the new index. Among these 16 measures, 12 were cognitive
measures (C) and 4 were behavioral measures (B). Although we
had longitudinal data from multiple time points, the change of
the last measure from baseline was used to avoid the violation
of the linear assumption of the longitudinal measures. For each
measure, we utilized the score and the average yearly change in
score based on the last measure and the baseline, comprising a
total of 32 predictors.

RESULTS
The characteristics of the participants that make up the data
set are shown in Table 1. Retired fighters as expected were
older and had more number of fights and years of fighting
than active fighters, whereas the controls tended to have a
slightly higher level of education than the active fighters (see
Supplementary Material). The proposed composite index is a
weighted linear value of the 12 standardized scores with 6 subscores: processing speed, choice reaction time, semantic fluency
(both total correct score and number of repeated words), letter
fluency (number of repeated words), and Barrett Impulsiveness
Scale Question 2 (I do things without thinking); and 6 yearly
change sub-scores that capture both the baseline difference and
the longitudinal change over time: choice reaction time, semantic
fluency (total correct and number of repeats), letter fluency
(number of repeats), Barrett Impulsiveness Scale question 2 and
6 (I have racing thoughts). Because the weighting of values
differed between active and retired fighters, two versions of the
RHICI emerged.
The range of the new index was from 0 to 20. We evaluated
the performance of the new index in the active fighters as
compared to the individual measures with regards to sensitivity.
The sensitivity was calculated as the mean and standard deviation

New Composite Index
Multivariate logistic regression models were employed to
compare active fighters with controls, and retired fighters
with controls to identify the predictors that could be used to
differentiate the groups. In a second step, linear discriminant
analysis was performed to derive the linear discriminant
coefficients for the three groups by using the predictors from the
two separate logistic regression models.
Assuming that CA and BA represent the average yearly
changes of cognitive measures and behavioral measures,
respectively, we standardized all the measures by using the range
of each measure from all samples. The multinomial logistic
regression between the active fighter group and the control group
was presented as:

TABLE 1 | Characteristics of study participants in the Professional Fighters Brain
Health Study that comprise the dataset used to develop the Repetitive Head
Impact Composite Index.

X
X
X
12
12
4
g(Pr(Y = j|X)) =
i=1 βi Ci +
i=1 γi CAi +
i=1 ϕi Bi
X
4
+
i=1 ωi BAi

Control

26 (15.8%)

22 (13.3%)

29.9 (6.3)

47.2 (10.0)

35.1 (14.7)

<0.0001

Education years

13.5 (2.0)

13.7 (2.1)

14.8 (2.8)

0.0496

16 (13.7%)

1 (3.9%)

2 (9.1%)

0.3390

Number of fights

9.6 (11.3)

34.3 (16.6)

0

<0.0001

Years of fighting

4.6 (4.4)

9.7 (5.1)

0

<0.0001

26 (22.2%)

3 (11.5%)

3 (13.6%)

White

55 (47.0%)

16 (61.5%)

11 (50.0%)

Other

36 (30.8%)

7 (26.9%)

8 (36.4%)

Race
African American

3

p-value

117 (70.9%)

Female
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Retired
fighters

Age

N

where g(p) = log[p/(1–p)] is the logit link function, X are the
observed data, and Y is the group with 0 for the control group
and 1 for the active fighter group. A similar logistic regression
model was used for the retired fighter group using the control
group as the reference group. We utilized the backward model
selection method with the p-value of 0.3 as the threshold to select

Active
fighters

0.5686
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been reported in the literature as affected in boxers and other
groups exposed to RHI (2, 7, 24, 25). However, some features
described in cohorts exposed to RHI did not enter our model.
Delayed memory did not emerge as a component of the RHICI
despite memory complaints by many with RHI and impaired
memory function being reported in individuals who had a
confirmed pathological diagnosis of CTE (8, 15, 25). The lack of
memory elements in the RHICI may reflect the predominance of
executive dysfunction associated with RHI or the limited method
for which we assessed memory function in the computerized
battery that was employed in the PABHS. As we accumulate
greater numbers of older retired fighters in our sample (or older
former athletes in other samples tested), it is possible that this
domain will enter the model and be added to the RHICI.
The structure and weighting of items in the RHICI differed
between active and retired fighters. The reason for this
difference is speculative. One possibility is that the underlying
pathophysiologic process may differ between these two groups.
In the active fighter group, RHICI may be measuring the effects
of accumulating axonal injury whereas the retired fighters may
include some who are harboring a neurodegenerative process
due to CTE. Longitudinal MRI regional volumetric data suggest
such a dichotomy (11). The practical implication is that in
implementing the RHICI, the specific version used would need
to be chosen based on whether the cohort is actively exposed to
RHI or is an older previously exposed group.
A unique feature of the RHICI is the inclusion of both current
values and rate of change from baseline in several elements.
The RHICI is not intended to be used as a diagnostic test
though a baseline score can be calculated to provide an anchor
point from which clinical trajectory can be followed. Commonly
used composite scales include measures that are thought to
be characteristic of a particular condition and can differentiate
patients from those without the disease. However, it is possible
that the rate of change of some of these components may also
be informative. By specifically assessing how certain tests change
over time and integrating these elements into the RHICI, we
expect this instrument to be of particular value in monitoring
longitudinal change or as an outcome measure in clinical trials.
The use of composite measures as endpoints in clinical trials
have been encouraged by the Food and Drug Administration
(FDA) and European Medical Agency (EMA) provided that the
measures are carefully designed, are relevant to existing tools for
which historical evidence exists and are validated in independent
prospective cohorts (26, 27). Given that the RHICI is based on
data derived from commonly used neuropsychological tools, the
first two requirements are met. However, the RHICI must be
validated in separate samples. Unlike other neurodegenerative
diseases such as Alzheimer’s disease where large longitudinal
datasets are publicly available, these types of data are more
limited for those exposed to RHI (28). The PFBHS has over 100
additional participants who will be undergoing their third time
point assessment next year; we will prospectively validate the
RHICI on the larger sample.
Moving forward, it will be essential to assess the RHICI
in other cohorts exposed to RHI if this tool is to have
broad application. While the version we describe is derived

TABLE 2 | Comparison of the mean and standard deviation ratio between the
Repetitive Head Impact Composite Index (RHICI) and individual scores on
processing speed, choice reaction time, or letter fluency tests.
Mean and standard deviation ratio
Active fighters (ratio)

Retire fighters (ratio)

RHICI

5.79 (1.00)

4.89 (1.00)

Processing speed score

2.23 (2.59)

2.38 (2.05)

Choice reaction time

1.94 (2.98)

2.66 (1.84)

Letter fluency total
correct score

1.96 (2.95)

1.69 (2.90)

ratio (MSDR) over a fixed follow-up time (e.g., 2 years). A
larger MSDR value represented a larger effect size, which leads
to greater sensitivity.
We computed the MSDR using the 2-year data of each fighter
(e.g., the 1st and 3rd visits). The MSDR (Table 2) showed that
the new index had better sensitivity compared to the individual
measures, with the ratio of MSDR of the new index to that of the
existing measures of at least 1.84.
We showed substantial improvement in sensitivity as
compared to the individual measures. The improved sensitivity
of the RHICI would be expected to reduce the sample size for
a clinical trial if used as an outcome measure. As an example,
consider a hypothetical 2-year study to detect a 5% decline from
baseline for active fighters using the existing measures, to attain
90% power at the significance level of 0.05. The required sample
size based on processing speed score was 126; it was reduced to
25 when the new index was used. Similar results were observed
when other measures were used in sample size calculations.

DISCUSSION
Assessment tools that are composed of elements of existing scales
thought most likely to detect change in a particular disease
are commonly used as outcome measures in clinical trials and
observational studies (21). There are several advantages to using
composite measures for clinical and research purposes including
improved power to detect change (thus potentially necessitating
fewer participants for clinical trials), avoiding arbitrary choices
between several important outcomes that occur in the same
disease, and serving as a common measure that is comparable
between groups (22, 23).
Though there has been increasing attention to the long-term
sequelae of RHI including CTE, no validated composite measure
is available. The RHICI is a first attempt using data-driven
methods to construct a composite scale to be used in tracking
longitudinal change and as a potential outcome measure in
studies related to neurological effects of RHI. The RHICI has the
advantage of easy administration on a desktop or tablet computer,
with most subtests performed on the device itself or the score
entered by the person supervising the testing (verbal fluency).
The components that constitute the RHICI currently,
including measures of processing speed, attention, executive
function and impulsivity, are consistent with domains that have
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CONCLUSIONS

from professional combatants, it is recognized that the clinical
presentation of those exposed to RHI is heterogenous and
potentially related to the type of exposure to RHI (29).
For example, among those exposed to RHI from American
Football there are groups that present at a younger age
with mainly behavioral symptoms, those that present at an
older age with primarily cognitive symptoms and a group
that presents with a mixture of cognitive and behavior (30).
Moreover, combat sports athletes generally will have more
motoric features (e.g., ataxia, parkinsonism) than those from
American Football. We would anticipate that perhaps elements
from other cognitive, behavioral or motor scales may eventually
be part of the RHICI as we examine this measure in
other groups.

There is an increasing need for tools to effectively track
individuals exposed to RHI. With the potential of treating the
consequences of RHI via clinical trials on the horizon, the
proposed Repetitive Head Impact Composite Index, a sensitive
measure to change in executive function, provides a standardized
approach evaluating long-term effects of RHI.
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Limitations
In developing the RHICI, we utilized all the cognitive and
behavioral data collected from the PFBHS, a longitudinal
observational study of active and professional fighters.
However, it is important to acknowledge the limitations of
this study. The extent of testing included several computerized
cognitive batteries and self-administered behavioral inventories
but was not exhaustive, particularly in surveying memory
and behavioral dysregulation. The number of participants
(particularly retired fighters and controls) who had complete
data for at least three time points was limited as was the
number of controls in the cohort. In regard to the latter, we
would anticipate as more data become available from our
cohort and others that the elements that comprise the RHICI
may be modified or weighted differently. The computerized
assessments used are proprietary, placing limitations on their
widespread use.
For the statistical models, several assumptions are made. With
multiple regression analysis and linear discriminant analysis, it is
assumed that there is a linear relationship between the outcome
and each independent variable. However, this assumption may
not be satisfied in clinically collected data and could lead to errors
in interpretation Furthermore, such models could be sensitive to
outliers (though the influence of such possible outliers becomes
smaller when the number of participants increases relative to the
number of predictor variables). Another assumption in these two
statistical models is the normality of independent variables. For
the three individual measures, we tested their normality by using
the Kolmogorov-Smirnov test. The normality of processing speed
and that of choice reaction time were satisfied with the p-values
above 0.05, while letter fluency total correct score fails to meet the
normality with the computed p-value below 0.05. A mathematical
function (e.g., log, arcsin) may be used to transform data to meet
the normality assumption.
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